NakamuraYYanagawaH.A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan. Eur J Pediatr. 1996;155(4):303-307. doi:10.1007/BF02002717.
2.
NakamuraYHiroseKYanagawaHKatoHKawasakiT.Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr. 1994;83(10):1061-1064. doi:10.1111/j.1651-2227.1994.tb12986.x.
3.
Gámez-GonzálezLBMurataCMuñoz-RamírezMYamazaki-NakashimadaM.Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr. 2013;172(3):337-342. doi:10.1007/s00431-012-1879-1.
4.
KanegayeJTWilderMSMolkaraD, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009;123(5):e783-e789. doi:10.1542/peds.2008-1871.
5.
LinMTFuCMHuangSKHuangSCWuMH.Population-based study of Kawasaki disease shock syndrome in Taiwan. Pediatr Infect Dis J. 2013;32(12):1384-1386. doi:10.1097/INF.0b013e31829efae6.
6.
İşgüderRDoksözÖBağÖ, et al. Kawasaki disease shock syndrome: a severe form of Kawasaki disease. Turk J Pediatr. 2013;55(3):319-321.
7.
SahaAKhalilSKapoorKGuptaADubeyNK.Kawasaki shock syndrome presenting as toxic shock syndrome. Int J Rheum Dis. 2013;16(4):480-482. doi:10.1111/1756-185X.12119.
8.
TremouletAHBestBMSongS, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153(1):117-121. doi:10.1016/j.jpeds.2007.12.021.
9.
TaddioARossiEDMonastaL, et al. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Clin Rheumatol. 2017;36(1):223-228. doi:10.1007/s10067-016-3316-8.
10.
KobayashiTKobayashiTMorikawaA, et al. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. J Pediatr. 2013;163(2):521-526. doi:10.1016/j.jpeds.2013.01.022.
11.
ChenSDongYYinYKrucoffMW.Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart. 2013;99(2):76-82. doi:10.1136/heartjnl-2012-302126.
12.
HokosakiTMoriMNishizawaT, et al. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease.Pediatr Int. 2012;54(1):99-103. doi:10.1111/j.1442-200X.2011.03487.x.
13.
ShumakKHRockGA.Therapeutic plasma exchange. N Engl J Med. 1984;310(12):762-771. doi:10.1056/NEJM198403223101206.
14.
HaradaTItoSShigaK, et al. A report of two cases of Kawasaki disease treated with plasma exchange. Ther Apher Dial. 2008;12(2):176-179. doi:10.1111/j.1744-9987.2008.00566.x.
15.
ThabetFBafaqihHAl-MohaimeedSAl-HilaliMAl-SewairiWChehabM.Shock: an unusual presentation of Kawasaki disease. Eur J Pediatr. 2011;170(7):941-943. doi:10.1007/s00431-011-1426-5.
